Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,531
datasets available to search
ShareScore release 0.9.0
Dataset results
2,531 results for “New combination”
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Da
ClinicalTrials.gov study NCT06269107. IPD Sharing: YES. Countries: 10. Publications: 0.
Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
ClinicalTrials.gov study NCT06820957. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer
ClinicalTrials.gov study NCT03803761. IPD Sharing: YES. Countries: 1. Publications: 0.
Effects of a New Combination of Nutraceuticals (AkP06) Without Monacolin K on Plasma Lipids and Glucose
ClinicalTrials.gov study NCT03340285. IPD Sharing: YES. Countries: 1. Publications: 0.
The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
ClinicalTrials.gov study NCT02393183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT06959537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) a
ClinicalTrials.gov study NCT07340619. IPD Sharing: NO. Countries: 0. Publications: 0.
A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)
ClinicalTrials.gov study NCT03333018. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Improving Care of Prader-Willi Syndrome : Evaluation of a New Care Program Combining Adapted Physical Activity, Nutrition and Therapeutic Education
ClinicalTrials.gov study NCT05249998. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago
ClinicalTrials.gov study NCT01587508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males
ClinicalTrials.gov study NCT05816356. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies
ClinicalTrials.gov study NCT07231458. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine/Ketoconazole
ClinicalTrials.gov study NCT01615913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
ClinicalTrials.gov study NCT04068194. IPD Sharing: YES. Countries: 1. Publications: 0.
A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD
ClinicalTrials.gov study NCT06557369. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
ClinicalTrials.gov study NCT05367440. IPD Sharing: YES. Countries: 4. Publications: 0.
Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World
ClinicalTrials.gov study NCT04515186. IPD Sharing: NO. Countries: 4. Publications: 0.
Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors
ClinicalTrials.gov study NCT03571438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia
ClinicalTrials.gov study NCT00670150. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00327743. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.